RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 86 filers reported holding RAPT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,662,910 | -24.3% | 761,908 | -14.9% | 0.00% | -50.0% |
| Q2 2023 | $16,736,987 | +17.8% | 895,026 | +15.6% | 0.00% | 0.0% |
| Q1 2023 | $14,206,113 | -5.4% | 774,175 | +2.1% | 0.00% | 0.0% |
| Q4 2022 | $15,012,063 | -19.2% | 758,185 | -1.8% | 0.00% | -33.3% |
| Q3 2022 | $18,581,000 | -2.4% | 772,275 | -26.0% | 0.00% | +50.0% |
| Q2 2022 | $19,044,000 | -18.0% | 1,043,552 | -1.2% | 0.00% | -33.3% |
| Q1 2022 | $23,222,000 | -36.8% | 1,055,957 | +5.6% | 0.00% | -40.0% |
| Q4 2021 | $36,725,000 | +54.9% | 999,873 | +30.9% | 0.01% | +66.7% |
| Q3 2021 | $23,714,000 | +115.2% | 763,744 | +120.3% | 0.00% | +200.0% |
| Q2 2021 | $11,022,000 | +733.1% | 346,729 | +481.9% | 0.00% | – |
| Q1 2021 | $1,323,000 | -29.4% | 59,583 | -37.2% | 0.00% | – |
| Q4 2020 | $1,874,000 | +2783.1% | 94,915 | +4617.4% | 0.00% | – |
| Q3 2020 | $65,000 | -71.6% | 2,012 | -74.6% | 0.00% | – |
| Q2 2020 | $229,000 | +4480.0% | 7,919 | +3617.8% | 0.00% | – |
| Q1 2020 | $5,000 | -93.9% | 213 | -92.7% | 0.00% | – |
| Q4 2019 | $82,000 | – | 2,925 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 2,680,621 | $49,189,395 | 17.79% |
| Euclidean Capital LLC | 432,900 | $7,943,715 | 6.97% |
| GREAT POINT PARTNERS LLC | 1,355,151 | $24,867,021 | 4.88% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 875,984 | $16,074,306 | 3.02% |
| Trustees of Columbia University in the City of New York | 80,580 | $1,478,643 | 2.64% |
| Perceptive Advisors | 2,291,608 | $42,051,007 | 1.24% |
| Cormorant Asset Management, LP | 650,000 | $11,928 | 0.79% |
| Alphabet Inc. | 540,270 | $9,913,955 | 0.55% |
| Redmile Group, LLC | 688,132 | $12,627,222 | 0.55% |
| Orbimed Advisors | 1,251,070 | $22,957,135 | 0.45% |